{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:31:39Z","timestamp":1762353099628,"version":"3.37.3"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T00:00:00Z","timestamp":1633132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T00:00:00Z","timestamp":1633132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1020567","1021409"],"award-info":[{"award-number":["1020567","1021409"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001787","name":"University of South Australia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001787","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002385","name":"Ministry of Higher Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002385","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Commonwealth Research and Training scholarship"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s12640-021-00405-2","type":"journal-article","created":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T12:45:50Z","timestamp":1633351550000},"page":"1689-1707","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Preclinical validation of a novel oral Edaravone formulation for treatment of frontotemporal dementia"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3181-0279","authenticated-orcid":false,"given":"Sally","family":"Kelliny","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larisa","family":"Bobrovskaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Fu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,2]]},"reference":[{"key":"405_CR1","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1001\/archneur.63.12.1763","volume":"63","author":"NT Aggarwal","year":"2006","unstructured":"Aggarwal NT, Wilson RS, Beck TL, Bienias JL, Bennett DA (2006) Motor dysfunction in mild cognitive impairment and the risk of incident Alzheimer disease. Arch Neurol 63:1763\u20131769","journal-title":"Arch Neurol"},{"key":"405_CR2","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.humimm.2013.06.009","volume":"74","author":"H Ahsan","year":"2013","unstructured":"Ahsan H (2013) 3-Nitrotyrosine: a biomarker of nitrogen free radical species modified proteins in systemic autoimmunogenic conditions. Hum Immunol 74:1392\u20131399","journal-title":"Hum Immunol"},{"key":"405_CR3","doi-asserted-by":"publisher","first-page":"151979","DOI":"10.1155\/2015\/151979","volume":"2015","author":"SM Alavi Naini","year":"2015","unstructured":"Alavi Naini SM, Soussi-Yanicostas N (2015) Tau hyperphosphorylation and oxidative stress, a critical vicious circle in neurodegenerative tauopathies? Oxid Med Cell Longev 2015:151979","journal-title":"Oxid Med Cell Longev"},{"key":"405_CR4","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1046\/j.1471-4159.1999.0730881.x","volume":"73","author":"DS Albers","year":"1999","unstructured":"Albers DS, Augood SJ, Martin DM et al (1999) Evidence for oxidative stress in the subthalamic nucleus in progressive supranuclear palsy. J Neurochem 73:881\u2013884","journal-title":"J Neurochem"},{"key":"405_CR5","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.neuropharm.2004.10.002","volume":"48","author":"M Banno","year":"2005","unstructured":"Banno M, Mizuno T, Kato H et al (2005) The radical scavenger edaravone prevents oxidative neurotoxicity induced by peroxynitrite and activated microglia. Neuropharmacology 48:283\u2013290","journal-title":"Neuropharmacology"},{"key":"405_CR6","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.freeradbiomed.2009.11.018","volume":"48","author":"SC Barber","year":"2010","unstructured":"Barber SC, Shaw PJ (2010) Oxidative stress in ALS: key role in motor neuron injury and therapeutic target. Free Radical Biol Med 48:629\u2013641","journal-title":"Free Radical Biol Med"},{"key":"405_CR7","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1093\/brain\/awr195","volume":"134","author":"JR Burrell","year":"2011","unstructured":"Burrell JR, Kiernan MC, Vucic S, Hodges JR (2011) Motor Neuron dysfunction in frontotemporal dementia. Brain 134:2582\u20132594","journal-title":"Brain"},{"key":"405_CR8","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1111\/j.1460-9568.2006.04986.x","volume":"24","author":"M Cente","year":"2006","unstructured":"Cente M, Filipcik P, Pevalova M, Novak M (2006) Expression of a truncated tau protein induces oxidative stress in a rodent model of tauopathy. Eur J Neurosci 24:1085\u20131090","journal-title":"Eur J Neurosci"},{"key":"405_CR9","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s40478-016-0382-8","volume":"4","author":"JD Cherry","year":"2016","unstructured":"Cherry JD, Tripodis Y, Alvarez VE et al (2016) Microglial neuroinflammation contributes to tau accumulation in chronic traumatic encephalopathy. Acta Neuropathol Commun 4:112\u2013112","journal-title":"Acta Neuropathol Commun"},{"key":"405_CR10","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/j.neurobiolaging.2013.12.023","volume":"35","author":"C Cook","year":"2014","unstructured":"Cook C, Dunmore JH, Murray ME et al (2014) Severe amygdala dysfunction in a MAPT transgenic mouse model of frontotemporal dementia. Neurobiol Aging 35:1769\u20131777","journal-title":"Neurobiol Aging"},{"key":"405_CR11","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1126\/science.7901908","volume":"262","author":"JT Coyle","year":"1993","unstructured":"Coyle JT, Puttfarcken P (1993) Oxidative stress, glutamate, and neurodegenerative disorders. Science 262:689\u2013695","journal-title":"Science"},{"key":"405_CR12","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1038\/cdd.2013.138","volume":"20","author":"S Dalleau","year":"2013","unstructured":"Dalleau S, Baradat M, Gu\u00e9raud F, Huc L (2013) Cell death and diseases related to oxidative stress:4-hydroxynonenal (HNE) in the balance. Cell Death Differ 20:1615\u20131630","journal-title":"Cell Death Differ"},{"key":"405_CR13","doi-asserted-by":"publisher","first-page":"23802","DOI":"10.1074\/jbc.M500356200","volume":"280","author":"DC David","year":"2005","unstructured":"David DC, Hauptmann S, Scherping I et al (2005) Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L tau transgenic mice. J Biol Chem 280:23802\u201323814","journal-title":"J Biol Chem"},{"key":"405_CR14","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1172\/JCI28769","volume":"117","author":"D Dias-Santagata","year":"2007","unstructured":"Dias-Santagata D, Fulga TA, Duttaroy A, Feany MB (2007) Oxidative stress mediates tau-induced neurodegeneration in Drosophila. J Clin Invest 117:236\u2013245","journal-title":"J Clin Invest"},{"key":"405_CR15","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.neuron.2012.06.026","volume":"75","author":"B DuBoff","year":"2012","unstructured":"DuBoff B, G\u00f6tz J, Feany MB (2012) Tau promotes neurodegeneration via DRP1 mislocalization in vivo. Neuron 75:618\u2013632","journal-title":"Neuron"},{"key":"405_CR16","doi-asserted-by":"publisher","first-page":"4063","DOI":"10.1096\/fj.11-186650","volume":"25","author":"M Dumont","year":"2011","unstructured":"Dumont M, Stack C, Elipenahli C et al (2011) Behavioral deficit, oxidative stress, and mitochondrial dysfunction precede tau pathology in P301S transgenic mice. FASEB J 25:4063\u20134072","journal-title":"FASEB J"},{"key":"405_CR17","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1523\/JNEUROSCI.5261-09.2010","volume":"30","author":"M Dutschmann","year":"2010","unstructured":"Dutschmann M, Menuet C, Stettner GM et al (2010) Upper airway dysfunction of Tau-P301L mice correlates with tauopathy in midbrain and ponto-medullary brainstem nuclei. J Neurosci 30:1810\u20131821","journal-title":"J Neurosci"},{"key":"405_CR18","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3233\/JAD-2011-111190","volume":"28","author":"C Elipenahli","year":"2012","unstructured":"Elipenahli C, Stack C, Jainuddin S et al (2012) Behavioral improvement after chronic administration of coenzyme Q10 in P301S transgenic mice. J Alzheimers Dis 28:173\u2013182","journal-title":"J Alzheimers Dis"},{"key":"405_CR19","doi-asserted-by":"crossref","unstructured":"Feng S, Yang Q, Liu M, et al. (2011) Edaravone for acute ischaemic stroke. Cochrane Database Syst Rev, Cd007230","DOI":"10.1002\/14651858.CD007230.pub2"},{"key":"405_CR20","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1089\/neu.2005.22.83","volume":"22","author":"SP Gabbita","year":"2005","unstructured":"Gabbita SP, Scheff SW, Menard RM et al (2005) Cleaved-tau: a biomarker of neuronal damage after traumatic brain injury. J Neurotrauma 22:83\u201394","journal-title":"J Neurotrauma"},{"key":"405_CR21","doi-asserted-by":"publisher","first-page":"14203","DOI":"10.1021\/bi001876l","volume":"39","author":"TC Gamblin","year":"2000","unstructured":"Gamblin TC, King ME, Kuret J, Berry RW, Binder LI (2000) Oxidative regulation of fatty acid-induced tau polymerization. Biochemistry 39:14203\u201314210","journal-title":"Biochemistry"},{"key":"405_CR22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0014-5793(97)00483-3","volume":"409","author":"M Goedert","year":"1997","unstructured":"Goedert M, Hasegawa M, Jakes R et al (1997) Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases. FEBS Lett 409:57\u201362","journal-title":"FEBS Lett"},{"key":"405_CR23","first-page":"21","volume":"149","author":"PF Good","year":"1996","unstructured":"Good PF, Werner P, Hsu A, Olanow CW, Perl DP (1996) Evidence of neuronal oxidative damage in Alzheimer\u2019s disease. Am J Pathol 149:21\u201328","journal-title":"Am J Pathol"},{"key":"405_CR24","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1074\/jbc.M006531200","volume":"276","author":"J G\u00f6tz","year":"2001","unstructured":"G\u00f6tz J, Chen F, Barmettler R, Nitsch RM (2001) Tau filament formation in transgenic mice expressing P301L tau. J Biol Chem 276:529\u2013534","journal-title":"J Biol Chem"},{"key":"405_CR25","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1146\/annurev-pathmechdis-012418-012936","volume":"14","author":"J G\u00f6tz","year":"2019","unstructured":"G\u00f6tz J, Halliday G, Nisbet R (2019) Molecular Pathogenesis of the Tauopathies. Ann Rev Pathol 14:239","journal-title":"Ann Rev Pathol"},{"key":"405_CR26","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/nrn2420","volume":"9","author":"J G\u00f6tz","year":"2008","unstructured":"G\u00f6tz J, Ittner LM (2008) Animal models of Alzheimer\u2019s disease and frontotemporal dementia. Nat Rev Neurosci 9:532\u2013544","journal-title":"Nat Rev Neurosci"},{"key":"405_CR27","first-page":"586","volume":"51","author":"AL Hampton","year":"2012","unstructured":"Hampton AL, Hish GA, Aslam MN et al (2012) Progression of ulcerative dermatitis lesions in C57BL\/6Crl mice and the development of a scoring system for dermatitis lesions. J Am Assoc Lab Anim Sci 51:586\u2013593","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"405_CR28","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.3390\/ijms20081959","volume":"20","author":"MM Haque","year":"2019","unstructured":"Haque MM, Murale DP, Kim YK, Lee J-S (2019) Crosstalk between oxidative stress and tauopathy. Int J Mol Sci 20:1959","journal-title":"Int J Mol Sci"},{"issue":"Suppl 1","key":"405_CR29","first-page":"S141","volume":"33","author":"F Hernandez","year":"2013","unstructured":"Hernandez F, Lucas JJ, Avila J (2013) GSK3 and tau: two convergence points in Alzheimer\u2019s disease. J Alzheimers Dis 33(Suppl 1):S141-144","journal-title":"J Alzheimers Dis"},{"key":"405_CR30","doi-asserted-by":"publisher","first-page":"5225","DOI":"10.1073\/pnas.1422998112","volume":"112","author":"S-S Jiao","year":"2015","unstructured":"Jiao S-S, Yao X-Q, Liu Y-H et al (2015) Edaravone alleviates Alzheimer\u2019s disease-type pathologies and cognitive deficits. Proc Natl Acad Sci U S A 112:5225\u20135230","journal-title":"Proc Natl Acad Sci U S A"},{"key":"405_CR31","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3233\/JAD-2004-6604","volume":"6","author":"ML Kashon","year":"2004","unstructured":"Kashon ML, Ross GW, O\u2019Callaghan JP et al (2004) Associations of cortical astrogliosis with cognitive performance and dementia status. J Alzheimers Dis 6:595\u2013604","journal-title":"J Alzheimers Dis"},{"key":"405_CR32","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.neurobiolaging.2012.11.010","volume":"34","author":"C K\u00f6hler","year":"2013","unstructured":"K\u00f6hler C, Dinekov M, G\u00f6tz J (2013) Active glycogen synthase kinase-3 and tau pathology-related tyrosine phosphorylation in pR5 human tau transgenic mice. Neurobiol Aging 34:1369\u20131379","journal-title":"Neurobiol Aging"},{"key":"405_CR33","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.brainres.2006.10.055","volume":"1129","author":"K-Y Lee","year":"2007","unstructured":"Lee K-Y, Koh S-H, Noh MY et al (2007) Glycogen synthase kinase-3\u03b2 activity plays very important roles in determining the fate of oxidative stress-inflicted neuronal cells. Brain Res 1129:89\u201399","journal-title":"Brain Res"},{"key":"405_CR34","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/78078","volume":"25","author":"J Lewis","year":"2000","unstructured":"Lewis J, McGowan E, Rockwood J et al (2000) Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat Genet 25:402\u2013405","journal-title":"Nat Genet"},{"key":"405_CR35","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3233\/JAD-2004-6610","volume":"6","author":"MA Lovell","year":"2004","unstructured":"Lovell MA, Xiong S, Xie C, Davies P, Markesbery WR (2004) Induction of hyperphosphorylated tau in primary rat cortical neuron cultures mediated by oxidative stress and glycogen synthase kinase-3. J Alzheimers Dis 6:659\u2013671","journal-title":"J Alzheimers Dis"},{"key":"405_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jcp.10119","volume":"192","author":"JL Martindale","year":"2002","unstructured":"Martindale JL, Holbrook NJ (2002) Cellular response to oxidative stress: signaling for suicide and survival*. J Cell Physiol 192:1\u201315","journal-title":"J Cell Physiol"},{"key":"405_CR37","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.bbadis.2011.10.006","volume":"1822","author":"P Mecocci","year":"2012","unstructured":"Mecocci P, Polidori MC (2012a) Antioxidant clinical trials in mild cognitive impairment and Alzheimer\u2019s disease. Biochim Biophys Acta 1822:631\u2013638","journal-title":"Biochim Biophys Acta"},{"key":"405_CR38","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.bbadis.2011.10.006","volume":"1822","author":"P Mecocci","year":"2012","unstructured":"Mecocci P, Polidori MC (2012b) Antioxidant clinical trials in mild cognitive impairment and Alzheimer\u2019s disease. Biochim Biophys Acta 1822:631\u2013638","journal-title":"Biochim Biophys Acta"},{"key":"405_CR39","doi-asserted-by":"publisher","first-page":"940603","DOI":"10.1155\/2013\/940603","volume":"2013","author":"S Mondrag\u00f3n-Rodr\u00edguez","year":"2013","unstructured":"Mondrag\u00f3n-Rodr\u00edguez S, Perry G, Zhu X et al (2013) Phosphorylation of tau protein as the link between oxidative stress, mitochondrial dysfunction, and connectivity failure: implications for Alzheimer\u2019s disease. Oxid Med Cell Longev 2013:940603\u2013940603","journal-title":"Oxid Med Cell Longev"},{"key":"405_CR40","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/297681a0","volume":"297","author":"RG Morris","year":"1982","unstructured":"Morris RG, Garrud P, Rawlins JN, O\u2019Keefe J (1982) Place navigation impaired in rats with hippocampal lesions. Nature 297:681\u2013683","journal-title":"Nature"},{"key":"405_CR41","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.freeradbiomed.2004.04.037","volume":"37","author":"H Nakashima","year":"2004","unstructured":"Nakashima H, Ishihara T, Yokota O et al (2004) Effects of alpha-tocopherol on an animal model of tauopathies. Free Radical Biol Med 37:176\u2013186","journal-title":"Free Radical Biol Med"},{"key":"405_CR42","volume-title":"Australian code for the care and use of animals for scientific purposes","author":"National Health and Medical Research Council","year":"2013","unstructured":"National Health and Medical Research Council (2013) Australian code for the care and use of animals for scientific purposes, 8 edn. NHMRC, Canberra","edition":"8"},{"key":"405_CR43","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3109\/09540261.2013.776523","volume":"25","author":"CU Onyike","year":"2013","unstructured":"Onyike CU, Diehl-Schmid J (2013) The epidemiology of frontotemporal dementia. Int Rev Psychiatry (abingdon, England) 25:130\u2013137","journal-title":"Int Rev Psychiatry (abingdon, England)"},{"key":"405_CR44","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.tips.2017.03.011","volume":"38","author":"ME Orr","year":"2017","unstructured":"Orr ME, Sullivan AC, Frost B (2017) A brief overview of tauopathy: causes, consequences, and therapeutic strategies. Trends Pharmacol Sci 38:637\u2013648","journal-title":"Trends Pharmacol Sci"},{"key":"405_CR45","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.2147\/DDDT.S161944","volume":"12","author":"A Parikh","year":"2018","unstructured":"Parikh A, Kathawala K, Li J et al (2018a) Self-nanomicellizing solid dispersion of edaravone: part II: in vivo assessment of efficacy against behavior deficits and safety in Alzheimer\u2019s disease model. Drug Des Devel Ther 12:2111\u20132128","journal-title":"Drug Des Devel Ther"},{"key":"405_CR46","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.2147\/DDDT.S161940","volume":"12","author":"A Parikh","year":"2018","unstructured":"Parikh A, Kathawala K, Tan CC, Garg S, Zhou X-F (2018b) Self-nanomicellizing solid dispersion of edaravone: part I - oral bioavailability improvement. Drug Des Devel Ther 12:2051\u20132069","journal-title":"Drug Des Devel Ther"},{"key":"405_CR47","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1601-183X.2005.00165.x","volume":"5","author":"L Pennanen","year":"2006","unstructured":"Pennanen L, Wolfer DP, Nitsch RM, G\u00f6tz J (2006) Impaired spatial reference memory and increased exploratory behavior in P301L tau transgenic mice. Genes Brain Behav 5:369\u2013379","journal-title":"Genes Brain Behav"},{"key":"405_CR48","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/S0014-5793(00)02323-1","volume":"486","author":"M P\u00e9rez","year":"2000","unstructured":"P\u00e9rez M, Cuadros R, Smith MA, Perry G, Avila J (2000) Phosphorylated, but not native, tau protein assembles following reaction with the lipid peroxidation product, 4-hydroxy-2-nonenal. FEBS Lett 486:270\u2013274","journal-title":"FEBS Lett"},{"key":"405_CR49","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1002\/ana.410430617","volume":"43","author":"P Poorkaj","year":"1998","unstructured":"Poorkaj P, Bird TD, Wijsman E et al (1998) Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol 43:815\u2013825","journal-title":"Ann Neurol"},{"key":"405_CR50","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.ejphar.2013.04.033","volume":"715","author":"N Rajasekar","year":"2013","unstructured":"Rajasekar N, Dwivedi S, Tota SK et al (2013) Neuroprotective effect of curcumin on okadaic acid induced memory impairment in mice. Eur J Pharmacol 715:381\u2013394","journal-title":"Eur J Pharmacol"},{"key":"405_CR51","doi-asserted-by":"publisher","first-page":"10637","DOI":"10.1523\/JNEUROSCI.3279-05.2005","volume":"25","author":"M Ramsden","year":"2005","unstructured":"Ramsden M, Kotilinek L, Forster C et al (2005) Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L). J Neurosci 25:10637\u201310647","journal-title":"J Neurosci"},{"key":"405_CR52","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/jps.23807","volume":"103","author":"W-T Rong","year":"2014","unstructured":"Rong W-T, Lu Y-P, Tao Q et al (2014) Hydroxypropyl-sulfobutyl-\u03b2-cyclodextrin improves the oral bioavailability of Edaravone by modulating drug efflux pump of enterocytes. J Pharm Sci 103:730\u2013742","journal-title":"J Pharm Sci"},{"key":"405_CR53","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.3233\/JAD-190226","volume":"71","author":"LK Rudenko","year":"2019","unstructured":"Rudenko LK, Wallrabe H, Periasamy A et al (2019) Intraneuronal tau misfolding induced by extracellular amyloid-\u03b2 oligomers. J Alzheimers Dis 71:1125\u20131138","journal-title":"J Alzheimers Dis"},{"key":"405_CR54","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/jcbfm.2013.196","volume":"34","author":"H Sancheti","year":"2014","unstructured":"Sancheti H, Kanamori K, Patil I et al (2014) Reversal of metabolic deficits by lipoic acid in a triple transgenic mouse model of Alzheimer\u2019s disease: a 13C NMR study. J Cereb Blood Flow Metab 34:288\u2013296","journal-title":"J Cereb Blood Flow Metab"},{"key":"405_CR55","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.powtec.2012.12.038","volume":"237","author":"RN Shamma","year":"2013","unstructured":"Shamma RN, Basha M (2013) Soluplus\u00ae: A novel polymeric solubilizer for optimization of Carvedilol solid dispersions: Formulation design and effect of method of preparation. Powder Technol 237:406\u2013414","journal-title":"Powder Technol"},{"key":"405_CR56","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1113\/expphysiol.1997.sp004024","volume":"82","author":"H Sies","year":"1997","unstructured":"Sies H (1997) Oxidative stress: oxidants and antioxidants. Exp Physiol 82:291\u2013295","journal-title":"Exp Physiol"},{"key":"405_CR57","doi-asserted-by":"publisher","first-page":"8948","DOI":"10.3390\/ijms21238948","volume":"21","author":"MC Silva","year":"2020","unstructured":"Silva MC, Haggarty SJ (2020) Tauopathies: deciphering disease mechanisms to develop effective therapies. Int J Mol Sci 21:8948","journal-title":"Int J Mol Sci"},{"key":"405_CR58","first-page":"7","volume":"14","author":"M Sinha","year":"2009","unstructured":"Sinha M, Hk A, Juyal R et al (2009) Edaravone in acute ischemic stroke, an Indian experience. Neurol Asia 14:7\u201310","journal-title":"Neurol Asia"},{"key":"405_CR59","doi-asserted-by":"publisher","first-page":"10540","DOI":"10.1073\/pnas.88.23.10540","volume":"88","author":"CD Smith","year":"1991","unstructured":"Smith CD, Carney JM, Starke-Reed PE et al (1991) Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc Natl Acad Sci U S A 88:10540\u201310543","journal-title":"Proc Natl Acad Sci U S A"},{"key":"405_CR60","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1126\/science.1355616","volume":"257","author":"ER Stadtman","year":"1992","unstructured":"Stadtman ER (1992) Protein oxidation and aging. Science 257:1220\u20131224","journal-title":"Science"},{"key":"405_CR61","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1083\/jcb.200108057","volume":"156","author":"K Stamer","year":"2002","unstructured":"Stamer K, Vogel R, Thies E, Mandelkow E, Mandelkow E-M (2002) Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J Cell Biol 156:1051\u20131063","journal-title":"J Cell Biol"},{"key":"405_CR62","doi-asserted-by":"publisher","first-page":"525","DOI":"10.2174\/156720508786898451","volume":"5","author":"B Su","year":"2008","unstructured":"Su B, Wang X, Nunomura A et al (2008) Oxidative stress signaling in Alzheimer\u2019s disease. Curr Alzheimer Res 5:525\u2013532","journal-title":"Curr Alzheimer Res"},{"key":"405_CR63","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/j.1471-4159.1990.tb08858.x","volume":"55","author":"KV Subbarao","year":"1990","unstructured":"Subbarao KV, Richardson JS, Ang LC (1990) Autopsy samples of Alzheimer\u2019s cortex show increased peroxidation in vitro. J Neurochem 55:342\u2013345","journal-title":"J Neurochem"},{"key":"405_CR64","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/j.1365-2990.2011.01232.x","volume":"38","author":"R Thangavel","year":"2012","unstructured":"Thangavel R, Stolmeier D, Yang X, Anantharam P, Zaheer A (2012) Expression of glia maturation factor in neuropathological lesions of Alzheimer\u2019s disease. Neuropathol Appl Neurobiol 38:572\u2013581","journal-title":"Neuropathol Appl Neurobiol"},{"key":"405_CR65","doi-asserted-by":"publisher","first-page":"e76057","DOI":"10.1371\/journal.pone.0076057","volume":"8","author":"L Wang","year":"2013","unstructured":"Wang L, Jiang Q, Chu J et al (2013) Expression of tau40 induces activation of cultured rat microglial cells. PLoS ONE 8:e76057","journal-title":"PLoS ONE"},{"key":"405_CR66","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrn.2015.1","volume":"17","author":"Y Wang","year":"2016","unstructured":"Wang Y, Mandelkow E (2016) Tau in physiology and pathology. Nat Rev Neurosci 17:5\u201321","journal-title":"Nat Rev Neurosci"},{"key":"405_CR67","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3164\/jcbn.17-62","volume":"62","author":"K Watanabe","year":"2018","unstructured":"Watanabe K, Tanaka M, Yuki S, Hirai M, Yamamoto Y (2018) How is edaravone effective against acute ischemic stroke and amyotrophic lateral sclerosis? J Clin Biochem Nutr 62:20\u201338","journal-title":"J Clin Biochem Nutr"},{"key":"405_CR68","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1527-3466.2008.00041.x","volume":"26","author":"T Watanabe","year":"2008","unstructured":"Watanabe T, Tahara M, Todo S (2008) The novel antioxidant Edaravone: from bench to bedside. Cardiovasc Ther 26:101\u2013114","journal-title":"Cardiovasc Ther"},{"key":"405_CR69","first-page":"1597","volume":"268","author":"T Watanabe","year":"1994","unstructured":"Watanabe T, Yuki S, Egawa M, Nishi H (1994) Protective effects of MCI-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions. J Pharmacol Exp Ther 268:1597\u20131604","journal-title":"J Pharmacol Exp Ther"},{"key":"405_CR70","doi-asserted-by":"publisher","first-page":"e0147733","DOI":"10.1371\/journal.pone.0147733","volume":"11","author":"A Wolf","year":"2016","unstructured":"Wolf A, Bauer B, Abner EL, Ashkenazy-Frolinger T, Hartz AM (2016) A comprehensive behavioral test battery to assess learning and memory in 129S6\/Tg2576 mice. PLoS ONE 11:e0147733","journal-title":"PLoS ONE"},{"key":"405_CR72","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1080\/13510002.1996.11747069","volume":"2","author":"Y Yamamoto","year":"1996","unstructured":"Yamamoto Y, Kuwahara T, Watanabe K, Watanabe K (1996) Antioxidant activity of 3-methyl-1-phenyl-2-pyrazolin-5-one. Redox Rep 2:333\u2013338","journal-title":"Redox Rep"},{"key":"405_CR71","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S0006-8993(97)00490-3","volume":"762","author":"T Yamamoto","year":"1997","unstructured":"Yamamoto T, Yuki S, Watanabe T et al (1997) Delayed neuronal death prevented by inhibition of increased hydroxyl radical formation in a transient cerebral ischemia. Brain Res 762:240\u2013242","journal-title":"Brain Res"},{"key":"405_CR73","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00401-014-1328-5","volume":"128","author":"M Yarchoan","year":"2014","unstructured":"Yarchoan M, Toledo JB, Lee EB et al (2014) Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer\u2019s disease and tauopathies. Acta Neuropathol 128:679\u2013689","journal-title":"Acta Neuropathol"},{"key":"405_CR74","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1527-3458.2006.00009.x","volume":"12","author":"H Yoshida","year":"2006","unstructured":"Yoshida H, Yanai H, Namiki Y et al (2006) Neuroprotective effects of Edaravone: a novel free radical scavenger in cerebrovascular injury. CNS Drug Rev 12:9\u201320","journal-title":"CNS Drug Rev"},{"key":"405_CR75","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1080\/14737175.2019.1581610","volume":"19","author":"H Yoshino","year":"2019","unstructured":"Yoshino H (2019) Edaravone for the treatment of amyotrophic lateral sclerosis. Expert Rev Neurother 19:185\u2013193","journal-title":"Expert Rev Neurother"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-021-00405-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12640-021-00405-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-021-00405-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T11:36:24Z","timestamp":1650281784000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12640-021-00405-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,2]]},"references-count":75,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["405"],"URL":"https:\/\/doi.org\/10.1007\/s12640-021-00405-2","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"type":"print","value":"1029-8428"},{"type":"electronic","value":"1476-3524"}],"subject":[],"published":{"date-parts":[[2021,10,2]]},"assertion":[{"value":"10 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"XFZ is one of the inventors of Chinese patent 200610149832.9. The authors report no other conflicts of interest in this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures were compliant with the approved protocol (U17-14, U13-18) from Animal Ethics Committee of the University of South Australia and the South Australia animal welfare act and the \u201cAustralian code of practice and use of animals for scientific purposes\u201d.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}